Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice

The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology (Baltimore, Md.) Md.), 2006-09, Vol.44 (3), p.581-591
Hauptverfasser: García‐Ruiz, Inmaculada, Rodríguez‐Juan, Cristina, Díaz‐Sanjuan, Teresa, del Hoyo, Pilar, Colina, Francisco, Muñoz‐Yagüe, Teresa, Solís‐Herruzo, José A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 591
container_issue 3
container_start_page 581
container_title Hepatology (Baltimore, Md.)
container_volume 44
creator García‐Ruiz, Inmaculada
Rodríguez‐Juan, Cristina
Díaz‐Sanjuan, Teresa
del Hoyo, Pilar
Colina, Francisco
Muñoz‐Yagüe, Teresa
Solís‐Herruzo, José A.
description The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; group II: C57BL/6J Lep(−/−) mice (ob/ob); group III, ob/ob mice treated with manganese [III] tetrakis (5,10,15,20 benzoic acid) porphyrin (MnTBAP); group IV, ob/ob mice treated with IgG1 immunoglobulin; group V, ob/ob mice treated with anti‐TNF antibody; group VI: ob/ob mice treated with uric acid. In liver tissue, we measured MRC activity, fatty acid β‐oxidation, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS), 3‐tyrosine‐nitrated proteins, 3‐tyrosine‐nitrated mitochondrial proteins, including cytochrome c and ND4 subunit of complex I. MRC activity was decreased in ob/ob mice. TNF levels, iNOS protein expression, and tyrosine nitrated proteins were markedly increased in the liver of ob/ob mice. In these animals, mitochondrial proteins were markedly tyrosine nitrated, particularly the ND4 subunit of complex I and cytochrome c. Treatment of these animals with uric acid, a peroxynitrite scavenger, anti‐TNF antibody, or MnTBAP decreased tyrosine nitrated proteins, improved the activity of MRC complexes, and led to a marked regression of hepatic steatosis and inflammation. In conclusion, MRC dysfunction and liver lesions found in ob/ob mice are likely to reflect the tyrosine nitration of mitochondrial proteins by peroxynitrite or a peroxynitrite‐derivate radical. Increased hepatic TNF and iNOS expression might enhance peroxynitrite formation and inhibition of MRC complexes. (HEPATOLOGY 2006;44:581–591.)
doi_str_mv 10.1002/hep.21313
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68818947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68818947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4193-b8c2a1b7be3c84336cc59f3bbe8eed730334b95694afe6232d8f22b2a85699023</originalsourceid><addsrcrecordid>eNp10MtKAzEUBuAgiq3VhS8gs1FwMW0uc0mWUlorFC_QrkOSydDIzKROOsrsfASf0Scx7Qx05eKQQ_g45_ADcI3gGEGIJxu9HWNEEDkBQxTjNCQkhqdgCHEKQ4YIG4AL594hhCzC9BwMUMIilFA8BG_r2qhAKJMFotrXzvx-_6ye54dW2qwNTLmt7acOSrOzamOrrDaiCLLW5U2ldsZWgakCKydWeqL0JTjLReH0Vf-OwHo-W00X4fLl8Wn6sAxVhBgJJVVYIJlKTRSNCEmUillOpNRU6ywlkJBIstgfKnKdYIIzmmMssaD-j0FMRuCum-uv-2i02_HSOKWLQlTaNo4nlCLKotTD-w6q2jpX65xva1OKuuUI8n1-3OfHD_l5e9MPbWSps6PsA_PgtgfCKVHktaiUcUdHYeojRt5NOvdlCt3-v5EvZq_d6j8i8ocB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68818947</pqid></control><display><type>article</type><title>Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>García‐Ruiz, Inmaculada ; Rodríguez‐Juan, Cristina ; Díaz‐Sanjuan, Teresa ; del Hoyo, Pilar ; Colina, Francisco ; Muñoz‐Yagüe, Teresa ; Solís‐Herruzo, José A.</creator><creatorcontrib>García‐Ruiz, Inmaculada ; Rodríguez‐Juan, Cristina ; Díaz‐Sanjuan, Teresa ; del Hoyo, Pilar ; Colina, Francisco ; Muñoz‐Yagüe, Teresa ; Solís‐Herruzo, José A.</creatorcontrib><description>The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; group II: C57BL/6J Lep(−/−) mice (ob/ob); group III, ob/ob mice treated with manganese [III] tetrakis (5,10,15,20 benzoic acid) porphyrin (MnTBAP); group IV, ob/ob mice treated with IgG1 immunoglobulin; group V, ob/ob mice treated with anti‐TNF antibody; group VI: ob/ob mice treated with uric acid. In liver tissue, we measured MRC activity, fatty acid β‐oxidation, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS), 3‐tyrosine‐nitrated proteins, 3‐tyrosine‐nitrated mitochondrial proteins, including cytochrome c and ND4 subunit of complex I. MRC activity was decreased in ob/ob mice. TNF levels, iNOS protein expression, and tyrosine nitrated proteins were markedly increased in the liver of ob/ob mice. In these animals, mitochondrial proteins were markedly tyrosine nitrated, particularly the ND4 subunit of complex I and cytochrome c. Treatment of these animals with uric acid, a peroxynitrite scavenger, anti‐TNF antibody, or MnTBAP decreased tyrosine nitrated proteins, improved the activity of MRC complexes, and led to a marked regression of hepatic steatosis and inflammation. In conclusion, MRC dysfunction and liver lesions found in ob/ob mice are likely to reflect the tyrosine nitration of mitochondrial proteins by peroxynitrite or a peroxynitrite‐derivate radical. Increased hepatic TNF and iNOS expression might enhance peroxynitrite formation and inhibition of MRC complexes. (HEPATOLOGY 2006;44:581–591.)</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.21313</identifier><identifier>PMID: 16941682</identifier><identifier>CODEN: HPTLD9</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Antibodies - therapeutic use ; Biological and medical sciences ; Blotting, Western ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Fatty Liver - drug therapy ; Fatty Liver - metabolism ; Fatty Liver - pathology ; Flow Cytometry ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatocytes - metabolism ; Hepatocytes - pathology ; Interferon-gamma - metabolism ; Interleukin-1 - metabolism ; Male ; Medical sciences ; Mice ; Mice, Inbred C57BL ; Mitochondria, Liver - drug effects ; Mitochondria, Liver - metabolism ; Mitochondrial Diseases - drug therapy ; Mitochondrial Diseases - metabolism ; Mitochondrial Diseases - pathology ; Nitric Oxide Synthase Type II - metabolism ; Treatment Outcome ; Tumor Necrosis Factor-alpha - immunology ; Uric Acid - therapeutic use</subject><ispartof>Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.581-591</ispartof><rights>Copyright © 2006 American Association for the Study of Liver Diseases</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4193-b8c2a1b7be3c84336cc59f3bbe8eed730334b95694afe6232d8f22b2a85699023</citedby><cites>FETCH-LOGICAL-c4193-b8c2a1b7be3c84336cc59f3bbe8eed730334b95694afe6232d8f22b2a85699023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.21313$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.21313$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18074281$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16941682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>García‐Ruiz, Inmaculada</creatorcontrib><creatorcontrib>Rodríguez‐Juan, Cristina</creatorcontrib><creatorcontrib>Díaz‐Sanjuan, Teresa</creatorcontrib><creatorcontrib>del Hoyo, Pilar</creatorcontrib><creatorcontrib>Colina, Francisco</creatorcontrib><creatorcontrib>Muñoz‐Yagüe, Teresa</creatorcontrib><creatorcontrib>Solís‐Herruzo, José A.</creatorcontrib><title>Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; group II: C57BL/6J Lep(−/−) mice (ob/ob); group III, ob/ob mice treated with manganese [III] tetrakis (5,10,15,20 benzoic acid) porphyrin (MnTBAP); group IV, ob/ob mice treated with IgG1 immunoglobulin; group V, ob/ob mice treated with anti‐TNF antibody; group VI: ob/ob mice treated with uric acid. In liver tissue, we measured MRC activity, fatty acid β‐oxidation, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS), 3‐tyrosine‐nitrated proteins, 3‐tyrosine‐nitrated mitochondrial proteins, including cytochrome c and ND4 subunit of complex I. MRC activity was decreased in ob/ob mice. TNF levels, iNOS protein expression, and tyrosine nitrated proteins were markedly increased in the liver of ob/ob mice. In these animals, mitochondrial proteins were markedly tyrosine nitrated, particularly the ND4 subunit of complex I and cytochrome c. Treatment of these animals with uric acid, a peroxynitrite scavenger, anti‐TNF antibody, or MnTBAP decreased tyrosine nitrated proteins, improved the activity of MRC complexes, and led to a marked regression of hepatic steatosis and inflammation. In conclusion, MRC dysfunction and liver lesions found in ob/ob mice are likely to reflect the tyrosine nitration of mitochondrial proteins by peroxynitrite or a peroxynitrite‐derivate radical. Increased hepatic TNF and iNOS expression might enhance peroxynitrite formation and inhibition of MRC complexes. (HEPATOLOGY 2006;44:581–591.)</description><subject>Animals</subject><subject>Antibodies - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Disease Models, Animal</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Fatty Liver - drug therapy</subject><subject>Fatty Liver - metabolism</subject><subject>Fatty Liver - pathology</subject><subject>Flow Cytometry</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatocytes - metabolism</subject><subject>Hepatocytes - pathology</subject><subject>Interferon-gamma - metabolism</subject><subject>Interleukin-1 - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mitochondria, Liver - drug effects</subject><subject>Mitochondria, Liver - metabolism</subject><subject>Mitochondrial Diseases - drug therapy</subject><subject>Mitochondrial Diseases - metabolism</subject><subject>Mitochondrial Diseases - pathology</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Treatment Outcome</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><subject>Uric Acid - therapeutic use</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MtKAzEUBuAgiq3VhS8gs1FwMW0uc0mWUlorFC_QrkOSydDIzKROOsrsfASf0Scx7Qx05eKQQ_g45_ADcI3gGEGIJxu9HWNEEDkBQxTjNCQkhqdgCHEKQ4YIG4AL594hhCzC9BwMUMIilFA8BG_r2qhAKJMFotrXzvx-_6ye54dW2qwNTLmt7acOSrOzamOrrDaiCLLW5U2ldsZWgakCKydWeqL0JTjLReH0Vf-OwHo-W00X4fLl8Wn6sAxVhBgJJVVYIJlKTRSNCEmUillOpNRU6ywlkJBIstgfKnKdYIIzmmMssaD-j0FMRuCum-uv-2i02_HSOKWLQlTaNo4nlCLKotTD-w6q2jpX65xva1OKuuUI8n1-3OfHD_l5e9MPbWSps6PsA_PgtgfCKVHktaiUcUdHYeojRt5NOvdlCt3-v5EvZq_d6j8i8ocB</recordid><startdate>200609</startdate><enddate>200609</enddate><creator>García‐Ruiz, Inmaculada</creator><creator>Rodríguez‐Juan, Cristina</creator><creator>Díaz‐Sanjuan, Teresa</creator><creator>del Hoyo, Pilar</creator><creator>Colina, Francisco</creator><creator>Muñoz‐Yagüe, Teresa</creator><creator>Solís‐Herruzo, José A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200609</creationdate><title>Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice</title><author>García‐Ruiz, Inmaculada ; Rodríguez‐Juan, Cristina ; Díaz‐Sanjuan, Teresa ; del Hoyo, Pilar ; Colina, Francisco ; Muñoz‐Yagüe, Teresa ; Solís‐Herruzo, José A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4193-b8c2a1b7be3c84336cc59f3bbe8eed730334b95694afe6232d8f22b2a85699023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Antibodies - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Disease Models, Animal</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Fatty Liver - drug therapy</topic><topic>Fatty Liver - metabolism</topic><topic>Fatty Liver - pathology</topic><topic>Flow Cytometry</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatocytes - metabolism</topic><topic>Hepatocytes - pathology</topic><topic>Interferon-gamma - metabolism</topic><topic>Interleukin-1 - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mitochondria, Liver - drug effects</topic><topic>Mitochondria, Liver - metabolism</topic><topic>Mitochondrial Diseases - drug therapy</topic><topic>Mitochondrial Diseases - metabolism</topic><topic>Mitochondrial Diseases - pathology</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Treatment Outcome</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><topic>Uric Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>García‐Ruiz, Inmaculada</creatorcontrib><creatorcontrib>Rodríguez‐Juan, Cristina</creatorcontrib><creatorcontrib>Díaz‐Sanjuan, Teresa</creatorcontrib><creatorcontrib>del Hoyo, Pilar</creatorcontrib><creatorcontrib>Colina, Francisco</creatorcontrib><creatorcontrib>Muñoz‐Yagüe, Teresa</creatorcontrib><creatorcontrib>Solís‐Herruzo, José A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>García‐Ruiz, Inmaculada</au><au>Rodríguez‐Juan, Cristina</au><au>Díaz‐Sanjuan, Teresa</au><au>del Hoyo, Pilar</au><au>Colina, Francisco</au><au>Muñoz‐Yagüe, Teresa</au><au>Solís‐Herruzo, José A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>2006-09</date><risdate>2006</risdate><volume>44</volume><issue>3</issue><spage>581</spage><epage>591</epage><pages>581-591</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><coden>HPTLD9</coden><abstract>The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; group II: C57BL/6J Lep(−/−) mice (ob/ob); group III, ob/ob mice treated with manganese [III] tetrakis (5,10,15,20 benzoic acid) porphyrin (MnTBAP); group IV, ob/ob mice treated with IgG1 immunoglobulin; group V, ob/ob mice treated with anti‐TNF antibody; group VI: ob/ob mice treated with uric acid. In liver tissue, we measured MRC activity, fatty acid β‐oxidation, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS), 3‐tyrosine‐nitrated proteins, 3‐tyrosine‐nitrated mitochondrial proteins, including cytochrome c and ND4 subunit of complex I. MRC activity was decreased in ob/ob mice. TNF levels, iNOS protein expression, and tyrosine nitrated proteins were markedly increased in the liver of ob/ob mice. In these animals, mitochondrial proteins were markedly tyrosine nitrated, particularly the ND4 subunit of complex I and cytochrome c. Treatment of these animals with uric acid, a peroxynitrite scavenger, anti‐TNF antibody, or MnTBAP decreased tyrosine nitrated proteins, improved the activity of MRC complexes, and led to a marked regression of hepatic steatosis and inflammation. In conclusion, MRC dysfunction and liver lesions found in ob/ob mice are likely to reflect the tyrosine nitration of mitochondrial proteins by peroxynitrite or a peroxynitrite‐derivate radical. Increased hepatic TNF and iNOS expression might enhance peroxynitrite formation and inhibition of MRC complexes. (HEPATOLOGY 2006;44:581–591.)</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16941682</pmid><doi>10.1002/hep.21313</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0270-9139
ispartof Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.581-591
issn 0270-9139
1527-3350
language eng
recordid cdi_proquest_miscellaneous_68818947
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals
subjects Animals
Antibodies - therapeutic use
Biological and medical sciences
Blotting, Western
Disease Models, Animal
Enzyme-Linked Immunosorbent Assay
Fatty Liver - drug therapy
Fatty Liver - metabolism
Fatty Liver - pathology
Flow Cytometry
Gastroenterology. Liver. Pancreas. Abdomen
Hepatocytes - metabolism
Hepatocytes - pathology
Interferon-gamma - metabolism
Interleukin-1 - metabolism
Male
Medical sciences
Mice
Mice, Inbred C57BL
Mitochondria, Liver - drug effects
Mitochondria, Liver - metabolism
Mitochondrial Diseases - drug therapy
Mitochondrial Diseases - metabolism
Mitochondrial Diseases - pathology
Nitric Oxide Synthase Type II - metabolism
Treatment Outcome
Tumor Necrosis Factor-alpha - immunology
Uric Acid - therapeutic use
title Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A42%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uric%20acid%20and%20anti%E2%80%90TNF%20antibody%20improve%20mitochondrial%20dysfunction%20in%20ob/ob%20mice&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Garc%C3%ADa%E2%80%90Ruiz,%20Inmaculada&rft.date=2006-09&rft.volume=44&rft.issue=3&rft.spage=581&rft.epage=591&rft.pages=581-591&rft.issn=0270-9139&rft.eissn=1527-3350&rft.coden=HPTLD9&rft_id=info:doi/10.1002/hep.21313&rft_dat=%3Cproquest_cross%3E68818947%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68818947&rft_id=info:pmid/16941682&rfr_iscdi=true